A new nanodevice designed by AIBN researchers analyses sugars on the surface of cellular messenger particles to catch early signs of lung cancer.
A new parcel of federal funding will help AIBN researchers produce clinical-grade mRNA products that are safer and better quality, and will potentially cost less.

Join The Network

Stay on top of our industry news and developments, events and opportunities, by joining The Network

Sign up today

Meet our researchers

Read now

Follow us




Professor Lianzhou Wang has been named UQ's first ever ARC Industry Laureate Fellow, winning $3.6 million to help position Australia as a leading supplier of superior batteries for electric vehicles.
Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.

Partner with us

Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.

General enquiries

Please direct general enquiries to our reception team

+61 7 3346 3877